OBJECTIVE: To determine whether measures of transitional zone volume (TZV) are more strongly associated than total prostate volume with longitudinal urologic outcomes. METHODS: In 1990, 2,115 randomly selected Caucasian men from Olmsted County, Minnesota (USA) completed validated questionnaires during a home visit. A 25% subsample underwent clinical evaluation that included transrectal ultrasonography, assessment of serum prostate-specific antigen levels, and maximum urinary flow rates. Examinations and questionnaires were repeated biennially through 2004. TZV measures were taken at the fifth through eighth visits. Men with at least one TZV measurement were included in this study (n=336). RESULTS: Changes in TZV correlated weakly with changes in peak urinary flow rate and urinary symptoms. After accounting for age and change in total prostate volume, change in TZV added no information to models that predict changes in urinary symptoms and peak urinary flow rates. Men who experienced the most rapid annual changes in TZV were not more likely to experience more rapid changes in urinary symptoms or maximum flow rate. CONCLUSION: Tracking changes in TZV over time may be unlikely to provide a good surrogate measure for the development of benign prostatic hyperplasia.
OBJECTIVE: To determine whether measures of transitional zone volume (TZV) are more strongly associated than total prostate volume with longitudinal urologic outcomes. METHODS: In 1990, 2,115 randomly selected Caucasian men from Olmsted County, Minnesota (USA) completed validated questionnaires during a home visit. A 25% subsample underwent clinical evaluation that included transrectal ultrasonography, assessment of serum prostate-specific antigen levels, and maximum urinary flow rates. Examinations and questionnaires were repeated biennially through 2004. TZV measures were taken at the fifth through eighth visits. Men with at least one TZV measurement were included in this study (n=336). RESULTS: Changes in TZV correlated weakly with changes in peak urinary flow rate and urinary symptoms. After accounting for age and change in total prostate volume, change in TZV added no information to models that predict changes in urinary symptoms and peak urinary flow rates. Men who experienced the most rapid annual changes in TZV were not more likely to experience more rapid changes in urinary symptoms or maximum flow rate. CONCLUSION: Tracking changes in TZV over time may be unlikely to provide a good surrogate measure for the development of benign prostatic hyperplasia.
Authors: Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Michael M Lieber; George G Klee; Kitaw Demissie; Steven J Jacobsen Journal: Urology Date: 2012-03 Impact factor: 2.649
Authors: Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen Journal: BJU Int Date: 2011-04-11 Impact factor: 5.588
Authors: Baris Turkbey; Robert Huang; Srinivas Vourganti; Hari Trivedi; Marcelino Bernardo; Pingkun Yan; Compton Benjamin; Peter A Pinto; Peter L Choyke Journal: BJU Int Date: 2012-09-14 Impact factor: 5.588
Authors: Michael M Lieber; Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Steven J Jacobsen; Jennifer L St Sauver Journal: BJU Int Date: 2009-07-07 Impact factor: 5.588
Authors: Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen Journal: Am J Epidemiol Date: 2009-04-24 Impact factor: 4.897
Authors: Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Ajay Nehra; Michael M Lieber; Steven J Jacobsen Journal: BJU Int Date: 2009-02-11 Impact factor: 5.588
Authors: Francesco Lotti; Giovanni Corona; Linda Vignozzi; Matteo Rossi; Elisa Maseroli; Sarah Cipriani; Mauro Gacci; Gianni Forti; Mario Maggi Journal: Asian J Androl Date: 2014 Mar-Apr Impact factor: 3.285